...
首页> 外文期刊>Nutrients >Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial
【24h】

Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial

机译:低热量饮食配合补充彩叶forskohlii提取物可降低超重和肥胖受试者代谢综合征的危险因素:一项随机对照试验

获取原文
           

摘要

Limited studies have shown that Coleus forskohlii extract may aid in weight management. This randomized, double blind placebo-controlled clinical study assessed the effects of supplementation with C. forskohlii extract on key markers of obesity and metabolic parameters in overweight and obese individuals. Thirty participants completed the trial and they were randomly assigned to receive either 250 mg of C. forskohlii extract (n = 15) or a placebo twice daily for 12 weeks. All participants were advised to follow a hypocaloric diet throughout the study. Body weight, body mass index (BMI), waist and hip circumference, and waist to hip ratio, were monitored fortnightly. Dietary intake was assessed at the baseline and weeks 4, 8 and 12. Appetite was assessed using visual analogue scales and blood samples were analyzed for plasma lipids, ghrelin, leptin, glucose and insulin at the baseline and end of the intervention. Significant reductions to waist and hip circumference (p = 0.02; p = 0.01, respectively) were recorded in both experimental and placebo groups after the 12 week intervention. Furthermore, high density lipoprotein-cholesterol (HDL-C) was significantly increased (p = 0.01) in both groups. The experimental group showed a favorable improvement in insulin concentration and insulin resistance (p = 0.001; 0.01 respectively) compared to the placebo group. These findings suggest that C. forskohlii extract in conjunction with a hypocaloric diet may be useful in the management of metabolic risk factors.
机译:有限的研究表明,彩叶提取物可能有助于体重控制。这项随机,双盲,安慰剂对照的临床研究评估了福寿螺提取物的补充对超重和肥胖个体肥胖和代谢参数关键指标的影响。 30名参与者完成了该试验,他们被随机分配接受250 mg的C. forskohlii提取物(n = 15)或安慰剂,每天两次,共12周。在整个研究过程中,建议所有参与者遵循低热量饮食。每两周监测一次体重,体重指数(BMI),腰围和臀围以及腰围与臀围的比率。在基线和第4、8和12周评估饮食摄入量。使用视觉模拟量表评估食欲,并在基线和干预结束时分析血样中的血脂,生长素释放肽,瘦素,葡萄糖和胰岛素。干预12周后,实验组和安慰剂组的腰围和髋围明显减少(分别为p = 0.02; p = 0.01)。此外,两组的高密度脂蛋白胆固醇(HDL-C)均显着升高(p = 0.01)。与安慰剂组相比,实验组的胰岛素浓度和胰岛素抵抗性均有改善(分别为p = 0.001; 0.01)。这些发现表明,福氏隐孢子虫提取物与低热量饮食一起可用于代谢危险因素的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号